Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Lifestyle changes remain the foundation
The global revenue for Invega products was $4.14 billion in 2022, a 2.93 percent increase from $4.02 billion in 2021
We caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from those made in or suggested by the forward-looking statements contained in this communication.
Patients should be encouraged to report any unusual or severe abdominal symptoms promptly rather than waiting for scheduled reviews
Mounjaro is FDA-approved to treat type 2 diabetes, while Zepbound is FDA-approved for chronic weight management and obstructive sleep apnea
US$ 24.90
US$ 27.06
US$ 27.73
US$ 29.75
US$ 19.99
US$ 22.78
US$ 24.43
